New diagnostic tool aims to end pancreatitis misdiagnosis

NCT ID NCT07536841

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new scoring system called OC26 to help doctors more accurately diagnose autoimmune pancreatitis, a condition where the immune system attacks the pancreas. Researchers will review medical data from 82 adults suspected of having the disease. If the OC26 criteria prove reliable, they could help distinguish autoimmune pancreatitis from other pancreatic conditions like cancer, leading to better treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide doctors with a more accurate and reliable tool to diagnose autoimmune pancreatitis, reducing misdiagnosis and unnecessary treatments.
What could go wrong
This is an observational study, not a treatment trial. The new criteria may not prove more accurate than existing methods, and results may not apply to all patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Military Medical Clinical Center of the Southern Region

    RECRUITING

    Odesa, Ukraine

  • Military Medical Clinical Center of the Southern Region

    RECRUITING

    Odesa, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.